Related Experiment Video
Updated: Jun 11, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Classical neurotransmitters and neuropeptides involved in major depression: a review
Felix-Martin Werner1, Rafael Coveñas
1Höhere Berufsfachschule für Altenpflege und Ergotherapie der Euro-Schulen Pössneck, Pössneck, Germany. felixm.werner@jetzweb.de
Abstract:
We propose several pathways that could be involved in major depression. According to our proposal, noradrenaline hypoactivity could occur through a strong presynaptic GABAergic inhibition, via GABA(B) receptors, and serotonin hypoactivity through a strong glutaminergic inhibition via subreceptor 5 of the metabotropic glutaminergic receptor. In this sense, it is important to know whether the antagonists of such receptors might be able to improve the symptoms observed in major depression. Some neuropeptides are also altered in such states (corticotropin-releasing hormone, neuropeptide Y, galanin). It is also important to know whether in addition to current antidepressants the administration of neuropeptides and their agonists/antagonists could ameliorate depressive symptoms.
Related Concept Videos
Neurotransmitters
Neurotransmitters
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...

